Biotech/Pharma Stocks Sector Close- Up; Vanda Pharmaceuticals Inc. (NASDAQ VNDA) up 637% on News FDA Approves Fanapt for the Treatment of Schizophreni

Biotech/Pharma Stocks Sector Close- Up; Vanda Pharmaceuticals Inc. (NASDAQ VNDA) up 637% on News FDA Approves Fanapt for the Treatment of Schizophrenia


POINT ROBERTS, Wash., May 7, 2009 http://www.biotechindustrystocks.com/, a global investor website for the biotechnology sector within Investorideas.com, presents a biotech stocks sector close- up following sharp gains in Vanda Pharmaceuticals Inc.(NasdaqGM: VNDA) , following news that the FDA approved Vanda Pharmaceuticals' Fanap for the treatment of Schizophrenia.

Other biotech stocks up on the day include Amgen Inc. (NasdaqGS: AMGN), Genzyme Corporation (NasdaqGS: GENZ) and Gilead Sciences, Inc. (NasdaqGS: GILD).

Biotech/Pharma Stocks Sector Close –Up Trading May 7, 2009
Amgen Inc. (NasdaqGS: AMGN) trading at $ 47.80, up $ 0.17 (0.36%) 1:24pm ET
Genzyme Corporation (NasdaqGS: GENZ) trading at $ 58.21, up 2.77 (5.00%) 1:17PM ET
Gilead Sciences, Inc. (NasdaqGS: GILD) trading at $45.33, up $ 1.30 (2.95%) 1:21PM ET
Vanda Pharmaceuticals Inc. (NasdaqGM: VNDA) trading at $ 7.97, up$ 6.89 (637.96%) 1:29PM ET

Company Snapshot:
Vanda Pharmaceuticals, Inc. (NasdaqGM: VNDA) Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. Its product portfolio includes Iloperidone (oral), a compound for the treatment of schizophrenia completed Phase III clinical trial; and Tasimelteon, which completed Phase III clinical trials for transient insomnia and chronic primary insomnia. The company’s products also comprise Iloperidone (Injectible) for the treatment of schizophrenia and Tasimelteon for the treatment of depression, which are in the Phase II initiation status.


The global Biotech Stocks Directory at Biotechindustrystocks.com and Investorideas.com features a directory of Medical Stocks, Life Sciences and Pharma Stocks for investors to research.

Visit the Biotech/Pharma Stock Directory: http://www.investorideas.com/Research/Biotech,PharmaStocks.asp

Biotech public and private companies can submit news releases at: http://www1.investorideas.com/NewsUploader/Default.aspx
Biotech Showcase companies: http://www.investorideas.com/About/companies.asp
Submit Biotech company profiles: http://www.investorideas.com/Profile/Submission.asp

About Biotechindustrystocks.com:
BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech sector, within Investorideas.com. Global visitors use the site daily to research the latest biotech stock and industry news, articles, audio, research reports and our stock directories.

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.

Investorideas.com Membership – Access full Biotech Stocks Directory, water stocks and more…
With markets and investor sentiment changing daily- it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the complete renewable energy stocks directory, water stocks, biotech and defense stocks directory, as well as the Insiders Corner by Michael Brush.
Become an InvestorIdeas.com -Learn more: http://www.investorideas.com/membership/

InvestorIdeas.com Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp
Our sites do not make recommendations, but offer information portals to investors to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of any information presented. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is compensated by featured companies, news submissions and online advertising.

For more information contact:
Dawn Van Zant 800.665.0411 dvanzant@investorideas.com
Or cvanzant@investorideas.com